Townsend John bought UNCY
July 28, 2025 · Form 4 insider transaction
Townsend John bought 10,000 shares of Unicycive Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
10,000
Price
$0.00
Total value
N/A
InsiderTownsend John
Role—
SecurityStock Options
Transaction codeA: Grant or award
Transaction dateJuly 28, 2025
Filing dateJuly 30, 2025
Shares owned after101,557
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
2,500 of the stock options vest on July 28, 2026 and 1/36th of the remaining options vest at the end of each successive month thereafter.